-
Welcure Drugs and Pharmaceuticals Ltd. Announces Acquisition of Leading Pharma Franchise in North India
The acquisition is expected to strengthen Welcure's presence in the North Indian market and bolster its product portfolio.
-
Welcure Drugs and Pharmaceuticals Ltd. Launches New Manufacturing Facility in Himachal Pradesh
The state-of-the-art facility will enhance Welcure's production capacity and support its growth strategy.
-
Welcure Drugs and Pharmaceuticals Ltd. Bags Prestigious Award for Quality Excellence
The company has been recognized for its commitment to manufacturing high-quality pharmaceutical products.
-
Welcure Drugs and Pharmaceuticals receives US FDA ANDA Approval for Mometasone Furoate Cream, USP, 0.1%
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on August 02, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Mometasone furoate Cream, USP, 0.1%.
-
Welcure Drugs and Pharmaceuticals Signs Exclusive Licensing Agreement with Dr. Reddy's Laboratories for Seven Products in the US Market
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has entered into an exclusive licensing agreement with Dr. Reddy's Laboratories Ltd. (Dr. Reddy's) for seven products in the US market.
-
Welcure Drugs and Pharmaceuticals Receives ANDA Approval from the US FDA for Acyclovir Tablets, USP, 800 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on July 19, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Acyclovir Tablets, USP, 800 mg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Fluticasone Propionate Nasal Spray, USP, 50 mcg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) announced recently that it has received the final approval, on June 20, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate Nasal Spray, USP, 50 mcg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Cetirizine Hydrochloride Tablets, USP, 10 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on May 16, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets, USP, 10 mg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Montelukast Sodium Chewable Tablets, USP, 10 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on April 25, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Chewable Tablets, USP, 10 mg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Famotidine Tablets, USP, 20 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on March 22, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Famotidine Tablets, USP, 20 mg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Propranolol Hydrochloride Tablets, USP, 10 mg and 40 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on February 22, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Applications (ANDAs) for Propranolol Hydrochloride Tablets, USP, 10 mg and 40 mg.
-
Welcure Drugs and Pharmaceuticals Receives US FDA Approval for its ANDA for Metoclopramide Hydrochloride Tablets, USP, 10 mg
Welcure Drugs & Pharmaceuticals Ltd. (Welcure) today announced that it has received the final approval, on January 18, 2023, from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Metoclopramide Hydrochloride Tablets, USP, 10 mg.